The effect of calcitriol, paricalcitol, and a calcimimetic on extraosseous calcifications in uremic rats
- 1 February 2008
- journal article
- Published by Elsevier in Kidney International
- Vol. 73 (3) , 300-307
- https://doi.org/10.1038/sj.ki.5002675
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Increased Parathyroid Hormone Gene Expression in Secondary Hyperparathyroidism of Experimental Uremia Is Reversed by CalcimimeticsJournal of the American Society of Nephrology, 2006
- Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns StudyKidney International, 2005
- Effect of the calcimimetic NPS R-467 on furosemide-induced nephrocalcinosis in the young ratKidney International, 2004
- Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidismKidney International, 2003
- Cardiac calcification in adult hemodialysis patientsJournal of the American College of Cardiology, 2002
- Effective suppression of parathyroid hormone by 1α-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidismKidney International, 1997
- Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patientsKidney International, 1992
- Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium.Journal of Clinical Investigation, 1989
- 1,25-dihydroxyvitamin D3 stimulates 45Ca2+-uptake by cultured vascular smooth muscle cells derived from rat aortaBiochemical and Biophysical Research Communications, 1988
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984